XML 50 R40.htm IDEA: XBRL DOCUMENT v3.20.2
License and Collaboration Agreements - Additional Information (Details) - Apollomics, Inc. - USD ($)
$ in Millions
1 Months Ended
Sep. 30, 2020
Jan. 31, 2020
Research and License Agreements    
Up-front payment received   $ 9.0
Milestones based on achievement of certain clinical and regulatory events   75.0
Milestone revenue recognized based on achievement of certain clinical and regulatory events $ 1.0  
Milestone payment upon achievement of specified net sales thresholds for all licensed products   $ 105.0
Maximum    
Research and License Agreements    
Tiered percentage of annual net sales   15.00%